CliffBio

Pragma

Patent cliffs & loss of exclusivity

Pragma is a South Korea-based education company, founded in 1996. It raised a $12M Series A in April 2021.

Company

AngelList URLhttps://angel.co/pragma
Seedtable URLhttps://seedtable.com/companies/pragma
Twitter URLhttp://twitter.com/seclab_pragma
Official Websitehttps://pragma.gg/
Wellfound IDpragma

5 upcoming patent cliffs

DrugIngredientTypeCliff
  1. MOXATAGAMOXICILLINSmall mol.May 2027
  2. DESYRELTRAZODONE HYDROCHLORIDESmall mol.Mar 2029
  3. DESYRELTRAZODONE HYDROCHLORIDESmall mol.Mar 2029
  4. DESYRELTRAZODONE HYDROCHLORIDESmall mol.Mar 2029
  5. DESYRELTRAZODONE HYDROCHLORIDESmall mol.Mar 2029
  6. KEFLEXCEPHALEXINSmall mol.—
  7. KEFLEXCEPHALEXINSmall mol.—
  8. KEFLEXCEPHALEXINSmall mol.—
  9. KEFLEXCEPHALEXINSmall mol.—
  10. KEFLEXCEPHALEXINSmall mol.—
  11. KEFLEXCEPHALEXINSmall mol.—
  12. KEFLEXCEPHALEXINSmall mol.—

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.